What is CompleWare?
CompleWare operates as a global clinical trial endpoint services provider, with a specialized focus across ophthalmology, respiratory, and oncology therapeutic areas. The company collaborates with Contract Research Organizations (CROs), pharmaceutical firms, and biotech enterprises to deliver dependable endpoint services essential for clinical trials. At its core, CompleWare leverages an innovative, cloud-based software solution that facilitates real-time data access and ensures compliance, irrespective of geographical constraints. This technological approach is designed to accelerate the advancement of therapeutic options for patients worldwide.
How much funding has CompleWare raised?
CompleWare has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for CompleWare?
The substantial late-stage funding and recent strategic investment signal a pivotal phase for CompleWare. This capital infusion is expected to fuel further expansion of its service offerings, enhance its technological infrastructure, and potentially broaden its market reach into new therapeutic areas or geographical regions. The company is well-positioned to capitalize on its established expertise in clinical trial endpoint services, aiming to solidify its role as a key partner for organizations seeking to bring novel treatments to market efficiently.
See full CompleWare company page
